Evidence map›Paper›PMID 26079395›Full record

ArticlePediatric pulmonology2015

Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma?

Karl Z Lukic, Allan L Coates

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Pediatric pulmonology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03839992 (The Measurement and Analysis of Maximal Expiratory Flow Volume Loops at Low Lung Volumes in Children With Cystic Fibrosis and Normal Routine Lung Function.), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03839992 recruitingnot on this mapstarted 2018, after this paper: background citation

The Measurement and Analysis of Maximal Expiratory Flow Volume Loops at Low Lung Volumes in Children With Cystic Fibrosis and Normal Routine Lung Function.

TypeobservationalSponsorGelb, Arthur F., M.D.Ran2018 to 2027Enrolled100ConditionsCystic Fibrosis in ChildrenArmsspirometry
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. ARTP statement on pulmonary function testing 2020.BMJ open respiratory research · 2020
    Guideline
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Bronchodilator Response in FEFRespiratory care · 2023
    Article
  10. Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2023
    Review
  11. Article
  12. Article
  13. Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2021
    Article
  14. Article
  15. Article
  16. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Karl Z LukicDepartment of Pediatrics, Hospital for Sick Children, Pulmonary Function Laboratory of the Division of Respiratory Medicine, University of Toronto, Toronto, Ontario, Canada.
Allan L CoatesDepartment of Pediatrics, Hospital for Sick Children, Pulmonary Function Laboratory of the Division of Respiratory Medicine, University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the FEV1 had been recognized as an excellent indicator of disability, it is not very sensitive to early and mild disease. In cystic fibrosis (CF) small airway disease is believed to be one of the early hallmarks and indices such as the FEF25-75 and FEF75 have been proposed as sensitive markers of early disease. The site of early disease in asthma is not as well worked out. Recently a study of more than 20,000 spirometries found that neither of these indices added anything to the FEV1 /FVC but that study was not disease specific and contained both adults and children and the adults were the most numerous. To see if this would be true in children, 1,175 spirograms from children 6 to 18 years of age with CF or asthma whose FEV1 and FVC were above the lower limit of normal were taken from sequential studies. The data expressed in z scores was plotted with either the FEF25-75 or FEF75 plotted against FEV1 /FVC. In both diseases, but particularly in asthma, the FEV1 /FVC was more likely to be abnormal than either of the other two indices for suggesting that for children, early, or mild disease will be more apparent using the FEV1 /FVC than any other index.

Indexed as

AdolescentAsthmaChildCystic FibrosisFemaleForced Expiratory Flow RatesForced Expiratory VolumeHumansMaleSpirometryVital Capacityasthmacystic fibrosisFEF25-75FEF75FEV1/FVCglobal lung initiativespirometry

Identifiers

PMID26079395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.